Insights

Expanded Access Focus ISCT maintains an Expanded Access Working Group actively issuing guidelines and governance resources for unproven and expanded access therapies, signaling ongoing demand for compliant program design, regulatory navigation, and patient access solutions that vendors can support with documentation, training, and software platforms.

Leadership & Strategic Hiring The appointment of a new Chief Commercialization Officer in 2025 indicates a formal push toward monetization, partnerships, and scalable programs, presenting opportunities for market intelligence services, channel partnerships, and targeted outreach to life science vendors seeking collaboration.

Global Collaboration ISCT frequently partners with major industry groups (ARM, ASGCT) and publishes joint statements, creating avenues to offer conference sponsorships, joint events, training cohorts, and digital collaboration tools that align with their governance and education initiatives.

Educational Programs The organization’s workforce development courses and guideline resources point to a sustained need for training platforms, content management, and certification tracking solutions that can be offered as scalable e-learning or LMS integrations for member institutions.

Public Policy & Compliance With public statements advocating moratoriums on HHGE and a focus on equitable access, there is potential to provide policy analytics, compliance tooling, and risk assessment services to ensure member organizations stay ahead of evolving regulations and reimbursement landscapes.

ISCT, International Society for Cell & Gene Therapy Tech Stack

ISCT, International Society for Cell & Gene Therapy uses 8 technology products and services including Leidos, WordPress, Microsoft PowerPoint, and more. Explore ISCT, International Society for Cell & Gene Therapy's tech stack below.

  • Leidos
    Cloud Infrastructure Computing
  • WordPress
    Content Management System
  • Microsoft PowerPoint
    Editors
  • Cerner
    Electronic Health Records
  • Mailchimp
    Email
  • React
    Javascript Frameworks
  • styled-components
    Javascript Frameworks
  • LinkedIn
    Online Community Software

Media & News

ISCT, International Society for Cell & Gene Therapy's Email Address Formats

ISCT, International Society for Cell & Gene Therapy uses at least 2 format(s):
ISCT, International Society for Cell & Gene Therapy Email FormatsExamplePercentage
First@celltherapysociety.orgJohn@celltherapysociety.org
83%
FLast@celltherapysociety.orgJDoe@celltherapysociety.org
17%
Middle@isctglobal.orgMichael@isctglobal.org
50%
First@isctglobal.orgJohn@isctglobal.org
50%

Frequently Asked Questions

What is ISCT, International Society for Cell & Gene Therapy's official website and social media links?

Minus sign iconPlus sign icon
ISCT, International Society for Cell & Gene Therapy's official website is isctglobal.org and has social profiles on LinkedIn.

What is ISCT, International Society for Cell & Gene Therapy's SIC code NAICS code?

Minus sign iconPlus sign icon
ISCT, International Society for Cell & Gene Therapy's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ISCT, International Society for Cell & Gene Therapy have currently?

Minus sign iconPlus sign icon
As of July 2026, ISCT, International Society for Cell & Gene Therapy has approximately 90 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Commercialization Officer: P. V.Honorary President: J. R.Director, Workforce Development Program Management: R. L.. Explore ISCT, International Society for Cell & Gene Therapy's employee directory with LeadIQ.

What industry does ISCT, International Society for Cell & Gene Therapy belong to?

Minus sign iconPlus sign icon
ISCT, International Society for Cell & Gene Therapy operates in the Biotechnology Research industry.

What technology does ISCT, International Society for Cell & Gene Therapy use?

Minus sign iconPlus sign icon
ISCT, International Society for Cell & Gene Therapy's tech stack includes LeidosWordPressMicrosoft PowerPointCernerMailchimpReactstyled-componentsLinkedIn.

What is ISCT, International Society for Cell & Gene Therapy's email format?

Minus sign iconPlus sign icon
ISCT, International Society for Cell & Gene Therapy's email format typically follows the pattern of First@celltherapysociety.org. Find more ISCT, International Society for Cell & Gene Therapy email formats with LeadIQ.

When was ISCT, International Society for Cell & Gene Therapy founded?

Minus sign iconPlus sign icon
ISCT, International Society for Cell & Gene Therapy was founded in 1992.
ISCT, International Society for Cell & Gene Therapy logo

ISCT, International Society for Cell & Gene Therapy

Biotechnology ResearchBritish Columbia, Canada51-200 Employees

ISCT, the International Society for Cell & Gene Therapy, is a global biotechnology research association focused on translating scientific research into innovative cellular therapies for patients. It is based in Vancouver, British Columbia, Canada, at 744 West Hastings Street, and has between 51 and 200 employees. The organization operates the Expanded Access Working Group, which develops guidelines and resources related to cell and gene therapy access and policy, and engages in collaborations with partner organizations. Recent activity includes partnering with the Alliance for Regenerative Medicine and the American Society for Gene & Cell Therapy to issue a joint statement, and leadership changes such as the appointment of Phil Vanek as Chief Commercialization Officer effective January 1, 2025. More information about its work is available on its website at https://isctglobal.org.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1992
Employees
51-200

Section iconFunding & Financials

  • $10M$25M

    ISCT, International Society for Cell & Gene Therapy's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    ISCT, International Society for Cell & Gene Therapy's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.